LONDON, Nov 16 : Flagship Pioneering is opening its first lab for creating companies outside the United States, putting £100 million ($131.94 million) behind a new UK-based effort to fund and build AI-driven biotech companies, the venture firm said on Monday.

The move is a first for a firm that has created more than 130 companies, including Moderna, and operated only from the United States for more than 25 years.

Flagship's move comes after three years of groundwork in Britain. The company opened its London office in 2023 near the Francis Crick Institute in King’s Cross and its local team has since built partnerships with academia, government…

Read the full article at CHANNELNEWSASIA.COM